JPRN-UMIN000029194
Completed
未知
Investigation of the effect of empagliflozin on cardiac sympathetic and parasympathetic nerve activity in Japanese patients with type 2 diabetes - EMPYREAN study
ConditionsDiabetes Mellitus (type 2)
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Diabetes Mellitus (type 2)
- Sponsor
- Shinshu University School of Medicine
- Enrollment
- 112
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Patients treated with insulin or GLP\-1 analogue 2\) Patients with eGFR\<45mL/min/1\.73m2 3\) Patients with Afib 4\) Patients implanted PM 5\) Patients who treated with beta\-blockers, alpha\-blokers, Digoxis, and CCB.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
The effect of Empagliflozin on outcomes of patients with myocardial infarction undergoing primary PCIIRCT20220809055645N7Rasht University of Medical Sciences54
Not yet recruiting
Phase 3
Evaluation of the effect of Empagliflozin on the severity of heart failure symptoms and echocardiography parameters in patients with congenital heart diseases with left-to-right shuntIRCT20120520009801N11Mashhad University of Medical Sciences44
Completed
Not Applicable
Evaluation of the effect of empagliflozin in combination with pioglitazone on fatty liver diseaseFatty liver.Fatty (change of) liver, not elsewhere classifiedK76.0IRCT20240208060939N1Artesh University of Medical Sciences80
Completed
Phase 1
Empagliflozin in non alcoholic fatty liverDiabetic patient with non alcoholic fatty liver.Other specified inflammatory liver diseasesK75.8IRCT20150706023084N18Islamic Azad University30
Recruiting
Phase 2
Evaluation of the effect of empagliflozin on prevention of atrial fibrillation after heart surgeryAtrial fibrillation after heart surgery.Paroxysmal atrial fibrillationIRCT20120520009801N9Mashhad University of Medical Sciences160